# Corrigendum: Neuroprotective effects of a novel peptide through the Rho-integrin-Tie2 and PI3K/Akt pathways in experimental autoimmune encephalomyelitis model

**Authors:** Wen Zhou, Han Qu, Xiao-Xiao Fu, Miao-Miao Xu, Qiang Li, Yuan Jiang, Shu Han

PMC · DOI: 10.3389/fphar.2025.1611105 · 2025-06-10

## Full-text entities

- **Genes:** RHO (rhodopsin) [NCBI Gene 6010] {aka CSNBAD1, OPN2, RP4}, TEK (TEK receptor tyrosine kinase) [NCBI Gene 7010] {aka CD202B, GLC3E, TIE-2, TIE2, VMCM, VMCM1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}
- **Diseases:** autoimmune encephalomyelitis (MESH:D004681)

---
Source: https://tomesphere.com/paper/PMC12185887